Day: May 3, 2022

The following primary insiders have today been allocated the following share options in Belships ASA: • Osvald Fossholm (CFO): 100 000 share optionsAfter the allocation, Fossholm has a total of 149 300 share options. In addition, he owns 55 000 shares in Belships ASA through his company Krino Invest AS. • Yngve Aslaksen Gram (VP Finance): 100 000 share optionsAfter the allocation, Gram has a total of 100 000 share options. In addition, he owns 200 000 shares. • 200 000 share options are distributed to other employees of Belships ASA. The strike price of this allocation is set at NOK 8.07 per share, which is equal to 105% of the share price after the general meeting on 25 May 2021 less dividends paid out. Belships has an option scheme for the company’s employees and the award is within the framework authorised at the general meeting...

LAS VEGAS, May 03, 2022 (GLOBE NEWSWIRE) — Alkame Holdings, Inc. (OTC PINK: ALKM), is pleased to announce that its wholly owned subsidiary, West Coast Copacker Inc., has completed the product development and has begun the production of CBDQ(9) initial line of hemp infused beverages. These “best in class” non-alcoholic beverage products were developed with the highest quality ingredients and under strict regulatory compliance and controls. The two products to come to market first are a 16.9oz Iced Tea and a Pink Lemonade, each both containing 25mg of high quality and environmentally friendly CBD, grown to organic standards. ‘We are very encouraged by the alliance formed between our companies. West Coast has helped us develop the first and only Iced Tea and Pink Lemonade infused with CBDQ(9) proprietary Ingredients in a bottle format....

National Eye Institute (NEI) to Collaborate with Curative Biotechnology under Cooperative Research and Development Agreement (CRADA) Boca Raton, FL, May 03, 2022 (GLOBE NEWSWIRE) — Curative Biotechnology, Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments for rare diseases and conditions, announced today the company has advanced into its Good Laboratory Practice (GLP) toxicology study. The current study is designed to gauge tolerability, pharmacokinetics and any local or systemic toxicity of reformulated metformin when administered by topical ocular delivery. The study will also assess its ocular tissue distribution. The Good Laboratory Practice (GLP) toxicology study is a requirement for an FDA Investigational New Drug (IND) filing. Ocular tolerance includes...

HERNDON, Va., May 03, 2022 (GLOBE NEWSWIRE) — Sysorex, Inc. (OTCQB: SYSX), a data center owner/operator centered on Ethereum mining and blockchain technology applications, and provider of goods and services pursuant to contracts with US Government agencies, shares the following letter from two of its largest shareholders, Bigger Capital Fund, LP and District 2 Capital Fund LP, which was filed yesterday with the Securities and Exchange Commission in a Form 13D. Bigger Capital Fund, LP and District 2 Capital Fund LP to Work with Sysorex to Maximize the Present Value Dear Fellow Shareholders, Bigger Capital Fund, LP and District 2 Capital Fund LP (together with its affiliates, the “Funds”), are now among the largest shareholders of Sysorex, Inc. (“Sysorex” or the “Company”), with ownership of approximately 9.6% of the Company’s outstanding...

The Supervisory Board of AS Merko Ehitus decided to extend the powers of a Member of the Management Board of the company, Mr. Tõnu Toomik until 6 June 2025 (inclusive). The Management Board of AS Merko Ehitus will continue with two members: Mr. Andres Trink (Chairman) and Mr. Tõnu Toomik. Urmas SomelarHead of FinanceAS Merko EhitusPhone: +372 650 1250E-mail: urmas.somelar@merko.ee AS Merko Ehitus (group.merko.ee) group companies develop real estate and construct buildings and infrastructure. We create a better living environment and build the future. We operate in Estonia, Latvia, Lithuania and Norway. As at the end of 2021, the group employed 670 people, and the group’s revenue for 2021 was EUR 339 million.

The Supervisory Board of Coop Pank AS decided on May 3rd, 2022 to recall Urmas Kaarlep from the Audit Committee position. The term of office of Urmas Kaarlep as a member of the Audit Committee expires on 03.05.2022. At the same time, the Supervisory Board of Coop Pank AS decided to appoint Stan Nahkor as a new member of the Audit Committee of the company, with position starting from 03.05.2022. Coop Pank, based on Estonian capital, is one of the five universal banks operating in Estonia. The number of clients using Coop Pank for their daily banking reached 122 400. Coop Pank aims to put the synergy generated by the interaction of retail business and banking to good use and to bring everyday banking services closer to people’s homes. The strategic shareholder of the bank is the domestic retail chain Coop Eesti, comprising of 330 stores. Additional...